Welcome Santo Therapeutics to SBC! Gallery Welcome Santo Therapeutics to SBC!sureyya hilmi2025-05-08T09:19:43+01:0007/05/2025|Read More
Nezar Clinical Services Joins SBC’s Seed Works Gallery Nezar Clinical Services Joins SBC’s Seed Workssureyya hilmi2025-04-30T11:40:59+01:0030/04/2025|Read More
Survey for mapping project aiming to advance commercialisation of UK life science products Gallery Survey for mapping project aiming to advance commercialisation of UK life science productssureyya hilmi2025-05-04T14:03:30+01:0029/04/2025|Read More
Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers Gallery Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancerssureyya hilmi2025-04-23T12:52:22+01:0023/04/2025|Read More
Catalyser applications now open! Gallery Catalyser applications now open!sureyya hilmi2025-03-31T12:00:43+01:0031/03/2025|Read More
SBC wins Best Performing R&D Facility for second year running at One Nucleus Awards Gallery SBC wins Best Performing R&D Facility for second year running at One Nucleus Awardssureyya hilmi2025-04-07T09:08:00+01:0027/03/2025|Read More
LifeArc Ventures is part of investor syndicate for Hillstar Bio who closes $67 million Series A financing round Gallery LifeArc Ventures is part of investor syndicate for Hillstar Bio who closes $67 million Series A financing roundsureyya hilmi2025-04-04T14:39:21+01:0025/03/2025|Read More
Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older Gallery Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and oldersureyya hilmi2025-04-04T14:23:54+01:0025/03/2025|Read More
Job Vacancy: Facilities Officer Gallery Job Vacancy: Facilities Officersureyya hilmi2025-03-24T14:28:19+00:0020/03/2025|Read More
Santo Therapeutics Begins Clinical Trial Targeting NF2-Related Tumours Gallery Santo Therapeutics Begins Clinical Trial Targeting NF2-Related Tumourssureyya hilmi2025-05-09T16:01:23+01:0020/03/2025|Read More
MFX Appoints Dr. Katy Newton as Chief Scientific Officer to Drive Innovation for Cell-Based Therapies Gallery MFX Appoints Dr. Katy Newton as Chief Scientific Officer to Drive Innovation for Cell-Based Therapiessureyya hilmi2025-04-03T17:27:53+01:0018/03/2025|Read More
Ternary Therapeutics Arrives at SBC Gallery Ternary Therapeutics Arrives at SBCsureyya hilmi2025-04-04T14:11:58+01:0014/03/2025|Read More
Mouthwash to treat side effects of cancer treatment (NG11-2) Phase-Ib clinical study results available Gallery Mouthwash to treat side effects of cancer treatment (NG11-2) Phase-Ib clinical study results availablesureyya hilmi2025-04-03T17:11:13+01:0003/03/2025|Read More
Monoclonal antibody delivers clinically meaningful and statistically significant improvements for patients with chronic rhinosinusitis with nasal polyps Gallery Monoclonal antibody delivers clinically meaningful and statistically significant improvements for patients with chronic rhinosinusitis with nasal polypssureyya hilmi2025-03-03T15:35:52+00:0001/03/2025|Read More
Network established to identify opportunities for regulation to support innovation within advanced therapies Gallery Network established to identify opportunities for regulation to support innovation within advanced therapiessureyya hilmi2025-03-03T12:51:32+00:0010/02/2025|Read More
Samuel Atack Appointed as Operations Director at Stevenage Bioscience Catalyst Gallery Samuel Atack Appointed as Operations Director at Stevenage Bioscience Catalystsureyya hilmi2025-02-07T15:10:08+00:0031/01/2025|Read More
Charles Large, Autifony CEO, talks at the 8th Sachs Neuroscience Innovation Forum in San Francisco Gallery Charles Large, Autifony CEO, talks at the 8th Sachs Neuroscience Innovation Forum in San Franciscosureyya hilmi2025-02-07T13:32:56+00:0029/01/2025|Read More
LifeArc and Neuropeutics Inc join forces to advance a new treatment for MND/ALS Gallery LifeArc and Neuropeutics Inc join forces to advance a new treatment for MND/ALSsureyya hilmi2025-03-03T12:59:20+00:0027/01/2025|Read More
New AI tool aims to detect early signs of dementia during routine eye tests Gallery New AI tool aims to detect early signs of dementia during routine eye testssureyya hilmi2025-03-03T13:15:23+00:0021/01/2025|Read More
Welcome INDICRO Ltd to Seed Works Shared Office! Gallery Welcome INDICRO Ltd to Seed Works Shared Office!sureyya hilmi2025-01-17T15:24:11+00:0017/01/2025|Read More